Evaluation of Acute and Convalescent Antibody Concentration Against Pneumococcal Capsular Polysaccharides for the Diagnosis of Pneumococcal Infection in Children with Community-Acquired Pneumonia
Journal article
Carter MJ. et al, (2024), Pediatric Infectious Disease Journal, 43, E67 - E70
Oral Valganciclovir Initiated beyond One Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.
Journal article
Kimberlin DW. et al, (2024), J Pediatr
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Journal article
Antimicrobial Resistance Collaborators None., (2024), Lancet Glob Health, 12, e201 - e216
The use of routinely collected electronic prescribing data to benchmark intravenous antibiotic use between two tertiary paediatric haematology-oncology inpatient units: a retrospective study.
Journal article
Channon-Wells S. et al, (2024), JAC Antimicrob Resist, 6
Development and application of the direct mycobacterial growth inhibition assay (MGIA): a systematic review
Journal article
MCSHANE H. et al, (2024), Frontiers in Immunology
Parental experience of neonatal pain research while participating in the Parental touch trial (Petal).
Journal article
van der Vaart M. et al, (2024), Pain
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health
Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media.
Journal article
Ruggeri K. et al, (2024), BMJ, 384
Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture
Journal article
Schurz H. et al, (2024), eLife, 13
Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK.
Journal article
Smith C. et al, (2024), BMJ Open, 14
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
Journal article
Martinez FJ. et al, (2024), NPJ Vaccines, 9
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike.
Journal article
Jung W. et al, (2024), NPJ Vaccines, 9
Evaluating the Impact of the BioFire FilmArray in Childhood Meningitis: An Observational Cohort Study.
Journal article
Kadambari S. et al, (2024), Pediatr Infect Dis J
Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population
Journal article
Doherty K. et al, (2024), Wellcome Open Research, 9, 2 - 2
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control.
Journal article
Wajja A. et al, (2024), Lancet Infect Dis
Artificial intelligence-assisted quantification and assessment of whole slide images for pediatric kidney disease diagnosis.
Journal article
Feng C. et al, (2024), Bioinformatics, 40
Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents.
Journal article
Sampson OL. et al, (2024), Front Immunol, 15